Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples